| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Obstetrics and Gynecology,*
Northwestern University Medical School, Department of Medicine,
Division of Infectious Diseases, Northwestern University Medical
School, Chicago, Illinois; Department of
Immunology/Microbiology,
Rush Medical College,
Chicago, Illinois; Department of Immunology, Microbiology,
Pathology, and Infectious Diseases,
Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden;
and Department of Medicine,§
Division of
Infectious Diseases, Northwestern University Medical School,
Chicago, Illinois
Sexually transmitted diseases, genital ulcer disease, and progesterone therapy increase susceptibility to lentivirus transmission. Infection of cells by human immunodeficiency virus (HIV) is dependent on expression of specific chemokine receptors known to function as HIV co-receptors. Quantitative kinetic reverse transcription-polymerase chain reaction was developed to determine the in vivo expression levels of CCR5, CXCR4, CCR3, CCR2b, and the cytomegalovirus-encoded US28 in peripheral blood mononuclear cells and cervical biopsies from 12 women with and without sexually transmitted diseases, genital ulcer disease, and progesterone-predominant conditions. Our data indicate that CCR5 is the major HIV co-receptor expressed in the female genital tract, and CXCR4 is the predominantly expressed HIV co-receptor in peripheral blood. CCR5 mRNA expression in the ectocervix was 10-fold greater than CXCR4, 20-fold greater than CCR2b, and 100-fold greater than CCR3. In peripheral blood, CXCR4 expression was 1.5-fold greater than CCR5, 10-fold greater than CCR2b, and 15-fold greater than CCR3. US28 was not expressed in cervical tissue despite expression in peripheral blood mononuclear cells from five individuals. CCR5 was significantly increased (p < 0.02) in biopsies from women with sexually transmitted diseases and others who were progesterone predominant. In vitro studies demonstrate that progesterone increases CCR5, CXCR4, and CCR3 expression and decreases CCR2b expression in lymphocytes and monocytes/macrophages. Characterization of chemokine receptors at the tissue level provides important information in identifying host determinants of HIV-1 transmission.
This article has been cited by other articles:
 |
|
 |
|
  L.A. Bergmeier and T. Lehner Innate and Adaptive Mucosal Immunity in Protection against HIV Infection Adv. Dent. Res., April 1, 2006; 19(1): 21 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.C. Herzberg, A. Weinberg, and S.M. Wahl (C3) The Oral Epithelial Cell and First Encounters with HIV-1 Adv. Dent. Res., April 1, 2006; 19(1): 158 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Venkataraman, A. L. Cole, P. Svoboda, J. Pohl, and A. M. Cole Cationic Polypeptides Are Required for Anti-HIV-1 Activity of Human Vaginal Fluid J. Immunol., December 1, 2005; 175(11): 7560 - 7567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Minnis and N S Padian Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions Sex. Transm. Inf., June 1, 2005; 81(3): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Laverdiere, B. H. Hoang, R. Yang, R. Sowers, J. Qin, P. A. Meyers, A. G. Huvos, J. H. Healey, and R. Gorlick Messenger RNA Expression Levels of CXCR4 Correlate with Metastatic Behavior and Outcome in Patients with Osteosarcoma Clin. Cancer Res., April 1, 2005; 11(7): 2561 - 2567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Philpott, H. Burger, C. Tsoukas, B. Foley, K. Anastos, C. Kitchen, and B. Weiser Human Immunodeficiency Virus Type 1 Genomic RNA Sequences in the Female Genital Tract and Blood: Compartmentalization and Intrapatient Recombination J. Virol., January 1, 2005; 79(1): 353 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Barassi, A. Lazzarin, and L. Lopalco CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects Blood, October 1, 2004; 104(7): 2205 - 2206. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Hu, I. Frank, V. Williams, J. J. Santos, P. Watts, G. E. Griffin, J. P. Moore, M. Pope, and R. J. Shattock Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue J. Exp. Med., April 19, 2004; 199(8): 1065 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. Kemal, B. Foley, H. Burger, K. Anastos, H. Minkoff, C. Kitchen, S. M. Philpott, W. Gao, E. Robison, S. Holman, et al. HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation PNAS, October 28, 2003; 100(22): 12972 - 12977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamura, F. O. Gulden, M. Sugaya, D. T. McNamara, D. L. Borris, M. M. Lederman, J. M. Orenstein, P. A. Zimmerman, and A. Blauvelt R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms PNAS, July 8, 2003; 100(14): 8401 - 8406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R J DiClemente, G M Wingood, C Del Rio, and R A Crosby Prevention interventions for HIV positive individuals Sex. Transm. Inf., December 1, 2002; 78(6): 393 - 395. [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Patterson, A. Landay, J. N. Siegel, Z. Flener, D. Pessis, A. Chaviano, and R. C. Bailey Susceptibility to Human Immunodeficiency Virus-1 Infection of Human Foreskin and Cervical Tissue Grown in Explant Culture Am. J. Pathol., September 1, 2002; 161(3): 867 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nagase, M. Miyamasu, M. Yamaguchi, M. Imanishi, N. H. Tsuno, K. Matsushima, K. Yamamoto, Y. Morita, and K. Hirai Cytokine-mediated regulation of CXCR4 expression in human neutrophils J. Leukoc. Biol., April 1, 2002; 71(4): 711 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Clerici, S. Declich, and G. Rizzardini African Enigma: Key Player in Human Immunodeficiency Virus Pathogenesis in Developing Countries? Clin. Vaccine Immunol., September 1, 2001; 8(5): 864 - 866. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Beisser, L. Laurent, J.-L. Virelizier, and S. Michelson Human Cytomegalovirus Chemokine Receptor Gene US28 Is Transcribed in Latently Infected THP-1 Monocytes J. Virol., July 1, 2001; 75(13): 5949 - 5957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Behbahani, E. Popek, P. Garcia, J. Andersson, A.-L. Spetz, A. Landay, Z. Flener, and B. K. Patterson Up-Regulation of CCR5 Expression in the Placenta Is Associated with Human Immunodeficiency Virus-1 Vertical Transmission Am. J. Pathol., December 1, 2000; 157(6): 1811 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maier, M. M. Bartolome-Rodriguez, C. Moulon, H. U. Weltzien, and A. Meyerhans Kinetics of CXCR4 and CCR5 up-regulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4+ T lymphocytes Blood, September 1, 2000; 96(5): 1853 - 1856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Greenhead, P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, and R. J. Shattock Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides J. Virol., June 15, 2000; 74(12): 5577 - 5586. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. E. Mackewicz, B. K. Patterson, S. A. Lee, and J. A. Levy CD8+ cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration J. Gen. Virol., May 1, 2000; 81(5): 1261 - 1264. [Abstract] [Full Text]
|
|
|
|
|
|
R. Kaul, F. A. Plummer, J. Kimani, T. Dong, P. Kiama, T. Rostron, E. Njagi, K. S. MacDonald, J. J. Bwayo, A. J. McMichael, et al. HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi J. Immunol., February 1, 2000; 164(3): 1602 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schramm, M. L. Penn, R. F. Speck, S. Y. Chan, E. De Clercq, D. Schols, R. I. Connor, and M. A. Goldsmith Viral Entry through CXCR4 Is a Pathogenic Factor and Therapeutic Target in Human Immunodeficiency Virus Type 1 Disease J. Virol., January 1, 2000; 74(1): 184 - 192. [Abstract] [Full Text]
|
|
|
|
|
|
L. G. Kostrikis, A. U. Neumann, B. Thomson, B. T. Korber, P. McHardy, R. Karanicolas, L. Deutsch, Y. Huang, J. F. Lew, K. McIntosh, et al. A Polymorphism in the Regulatory Region of the CC-Chemokine Receptor 5 Gene Influences Perinatal Transmission of Human Immunodeficiency Virus Type 1 to African-American Infants J. Virol., December 1, 1999; 73(12): 10264 - 10271. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. B. Urnovitz, J. C. Sturge, T. D. Gottfried, and W. H. Murphy Urine Antibody Tests: New Insights into the Dynamics of HIV-1 Infection Clin. Chem., September 1, 1999; 45(9): 1602 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. Spetz, B. K. Patterson, K. Lore, J. Andersson, and L. Holmgren Functional Gene Transfer of HIV DNA by an HIV Receptor-Independent Mechanism J. Immunol., July 15, 1999; 163(2): 736 - 742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vassiliadou, L. Tucker, and D. J. Anderson Progesterone-Induced Inhibition of Chemokine Receptor Expression on Peripheral Blood Mononuclear Cells Correlates with Reduced HIV-1 Infectability In Vitro J. Immunol., June 15, 1999; 162(12): 7510 - 7518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-j. Zhang and J. P. Moore Will Multiple Coreceptors Need To Be Targeted by Inhibitors of Human Immunodeficiency Virus Type 1 Entry? J. Virol., April 1, 1999; 73(4): 3443 - 3448. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
